COVID-19/SARS-COV-2 / RESEARCH LETTER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Amantadine is a well-known medication with indications in neurology and infectious diseases. It is currently FDA approved for Parkinson disease, drug induced extrapyramidal symptoms, and influenza.

Material and methods:
The article is author's original research hypothesis.

Results:
As more people are going to be vaccinated and more similar vaccines are going to be introduced, we should take into consideration a potential of amantadine to interfere with LNP-mRNA COVID-19 vaccine delivery into the target cells.

Conclusions:
A more cautious approach to the patients taking amantadine as far as vaccination utilizing LNP-mRNA platform should be considered.

eISSN:1896-9151
ISSN:1734-1922